Pfizer Overview
- Founded
- 1849
- Status
- Public
- Employees
- 88,300
- Stock Symbol
- PFE
- Investments
- 99
- Share Price
- $38.31
- (As of Monday Closing)
Pfizer General Information
Description
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion. Pfizer also spends a leading amount on research and development, close to $8 billion annually. While Pfizer historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.
Contact Information
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Discovery Tools (Healthcare)
Biotechnology
Stock Exchange
NYS
Primary Office
- 235 East 42nd Street
- New York, NY 10017
- United States
+1 (212) 000-0000
Pfizer Stock Performance
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $38.31 | $37.23 | $26.41 - $39.78 | $207B | 5.56B | 34.3M | $1.56 |
Pfizer Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
|---|---|---|---|---|
| EV | 256,396,489 | 260,711,914 | 283,866,715 | 243,284,819 |
| Revenue | 48,649,000 | 51,750,000 | 53,647,000 | 52,546,000 |
| EBITDA | 15,104,000 | 25,040,000 | 19,252,000 | 19,453,000 |
| Net Income | 8,686,000 | 16,273,000 | 11,153,000 | 21,308,000 |
| Total Assets | 178,983,000 | 167,489,000 | 159,422,000 | 171,797,000 |
| Total Debt | 61,528,000 | 52,150,000 | 41,740,000 | 43,492,000 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Pfizer Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Pfizer‘s full profile, request access.
Request a free trialPfizer Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion. Pfizer also spends a
Pharmaceuticals
New York, NY
88,300
As of 2019
000000 - 000
00000000
rehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat c
000000000000000
Brentford, United Kingdom
00000
As of 0000
00000000000
00000000
it esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt
000000000000000
Basel, Switzerland
000000
As of 0000
000000000000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialPfizer Competitors (18)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| GlaxoSmithKline | Corporation | Brentford, United Kingdom | 00000 | 00000000000 | ||
| 00000000 | Corporation | Basel, Switzerland | 000000 | 000000000000 | ||
| 00000000000 | Formerly PE-Backed | Cambridge, United Kingdom | 00000 | 000 | 00000000 | 000 |
| 0000000 & 0000000 | Corporation | New Brunswick, NJ | 000000 | 0000 | ||
| 000000 00000000000 | Corporation | Tokyo, Japan | 00000 | 00000000 |
Pfizer Executive Team (322)
Pfizer Board Members (24)
| Name | Representing | Role | Since |
|---|---|---|---|
| 000000 000000 00.0 | Pfizer | Chief Executive Officer & Chairman | 000 0000 |
| 000 0000000 00.0 | Pfizer | Board Member | 000 0000 |
| 00000 0000000 | Pfizer | Director, Portfolio Director & Planning Lead, PMP, Pfizer Oncology | 000 0000 |
| 000 00000000 | Self | Board Member | 000 0000 |
| 00000 00000 | Pfizer | Board Member | 000 0000 |
Pfizer Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialPfizer Investments & Acquisitions (99)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000 | 16-Nov-2020 | 000000000000000000 | 0000 | Pharmaceuticals | 000000 000000 00.0 |
| 0000000 | 29-Oct-2020 | 00000 00000 00 | 00000 | Biotechnology | |
| 0000000 0000000000 | 27-Oct-2020 | 0000 | 00000 | Drug Discovery | 0000000 00000000 |
| 00000 000000000000 | 22-Oct-2020 | 000000000000000000 | Drug Discovery | 000000000 00000000 | |
| CStone Pharmaceuticals | 30-Sep-2020 | PIPE | 00000 | Biotechnology |
Pfizer Subsidiaries (21)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Arixa Pharmaceuticals | Drug Discovery | Palo Alto, CA | 2016 |
| 000000 00000000000 | Biotechnology | Chapel Hill, NC | 0000 |
| 0000000000 | Pharmaceuticals | Piscataway Township, NJ | 0000 |
| 0000000 000(0) 000 | Corporate Pension | Peapack, NJ | 0000 |
| 0000000 | Medical Supplies | Lake Forest, IL | 0000 |
Pfizer Exits (25)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 00000000 | 04-Jan-2019 | 000000000 | 00000 | Completed |
|
| 0000000 0000000000 | 01-Nov-2017 | 000000000 | 00000 | Completed |
|
| 00 000000 00000000 | 13-Dec-2016 | 000000000 | Completed |
|
|
| 00000000 000000000 | 04-Aug-2016 | 000 | 0000 | Completed |
|
| Gemphire Therapeutics | 09-Mar-2016 | Early Stage VC | 000.00 | Completed |
|